issued
on 17 Sep 2024
Last Applicant/ Owned by
c/o STIEFLER LAW, 100 FIFTH AVE #A-1
NEW YORK
NY
10001
Serial Number
98221719 filed on 12th Oct 2023
Registration Number
N/A
Correspondent Address
Ellen Stiefler
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Medical devices for use in treating or diagnosing sepsis and inflammatory disease using a non-invasive patch to record and measure biological signs, cytokine signals and neural signals; Medical devices for use in treating or diagnosing sepsis and inflammatory disease using a non-invasive patch to record and measure biological signs, cytokine signals and neural signals with integrated recorded oper Read More
Medical devices for use in treating or diagnosing sepsis and inflammatory disease using a non-invasive patch to record and measure biological signs, cytokine signals and neural signals; Medical devices for use in treating or diagnosing sepsis and inflammatory disease using a non-invasive patch to record and measure biological signs, cytokine signals and neural signals with integrated recorded operating system software, sold as a unit; Medical devices for use in treating or diagnosing sepsis and inflammatory disease using a non-invasive patch to record and measure biological signs, cytokine signals and neural signals with integrated recorded software using artificial intelligence, machine learning, and deep learning to decode nervous system language response signals to detect sepsis and inflammatory disease, sold as a unit
N/A
N/A
No 98221719
No Service/Collective Mark
No
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
17th Sep 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
23rd Jul 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
23rd Jul 2024 | PUBLISHED FOR OPPOSITION |
03rd Jul 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
18th Jun 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
10th Jun 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
10th Jun 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
10th Jun 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
06th Jun 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
06th Jun 2024 | NON-FINAL ACTION WRITTEN |